You are here:
Information Letter on Tasigna®
active substance: nilotinib
2009.09.15
Active substance: nilotinib
The Federal Institute for Drugs and Medical Devices (BfArM) requests consideration of the Information letter concerning the medicinal product Tasigna® (active substance: nilotinib)